CLINICAL_TRIALS
approval
· 2026-02-18
Clinical Trial Update: Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of the Thoracoabdominal and Pararenal Aortic Aneurysms (TAMBE)
Summary
The TAMBE trial evaluating the GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis has been approved for marketing for the treatment of thoracoabdominal aneury…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: W.L.Gore & Associates | Conditions: Thoracoabdominal Aneurysm | Status: APPROVED_FOR_MARKETING